ArticleHeliyon2024
Technical considerations regarding saliva sample collection to achieve comparable protein identification and detection via one- and two-dimensional gel electrophoresis among humans.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: Recently, demands towards identifying various molecules in support of stress detection and potential clinical utilization are dramatically increasing. Moreover, the accuracy with which researchers quantify these informative molecules is now far more improved when compared to the past. As RNA or protein markers are conventionally detected via repeated invasive procedures from blood, it is critical to develop secure technologies to obtain the desired information via less stressful methodologies, such as saliva collection. Moreover, for superb interpretation, it became equally significant to obtain the information from the same exact specimen. RNA is easily degradable, thus it is paramount to supplement the samples with protective agents, such as RNAlater, to achieve accurate quantitative results. Methods: In our research we investigated whether and how this commonly applied RNA protection procedure influences protein and peptide separation of the human saliva via quantitative two-dimensional protein electrophoresis. Results: Our results revealed, in contrary to previously published data regarding plasma, the addition of RNAlater to saliva samples negatively influences isoelectric focusing and protein detection. We equally found the application oftentimes employed referred to as selective precipitation and reduction-alkylation, partially rescued separation, however, with a significant loss in protein yield and quality when compared to untreated samples. Conclusion: Our results suggest collection of human saliva for biomarker identification must be performed with extreme diligence. We propose application of RNAlater should be avoided and snap freezing of the collected saliva is recommended when joint protein and RNA quantification is the ultimate goal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.